Hanneke van der Wijngaart

Research output

Research output per year 2017 2019 2022 2023 2023

• 11 Article
• 1 Review article
• 1 Phd-Thesis - Research and graduation internal

Research output per year

Research output per year

Search results

• 2023

  Advancing wide implementation of precision oncology: A liquid nitrogen-free snap freezer preserves molecular profiles of biological samples

  van der Wijngaart, H., Jagga, S., Dekker, H., de Goeij, R., Piersma, S. R., Pham, T. V., Knol, J. C., Zonderhuis, B. M., Holland, H. J., Jiménez, C. R., Verheul, H. M. W., Vanapalli, S. & Labots, M., May 2023, In: Cancer Medicine. 12, 9, p. 10979-10989 11 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access

• Candidate biomarkers for treatment benefit from sunitinib in patients with advanced renal cell carcinoma using mass spectrometry-based (phospho)proteomics

  van der Wijngaart, H., Beekhof, R., Knol, J. C., Henneman, A. A., de Goeij-de Haas, R., Piersma, S. R., Pham, T. V., Jimenez, C. R., Verheul, H. M. W. & Labots, M., 1 Dec 2023, In: Clinical Proteomics. 20, 1, 49.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  1 Citation (Scopus)

• Clinical application of genomics- and phosphoproteomics-based selection of targeted therapy in patients with advanced solid tumors

  van der Wijngaart, H., 15 Dec 2023, 204 p.

  Research output: PhD Thesis › Phd-Thesis - Research and graduation internal

  Open Access

• Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours

  Geurts, B. S., Battaglia, T. W., van Berge Henegouwen, J. M., Zeverijn, L. J., de Wit, G. F., Hoes, L. R., van der Wijngaart, H., van der Noort, V., Roepman, P., de Leng, W. W. J., Jansen, A. M. L., Opdam, F. L., de Jonge, M. J. A., Cirkel, G. A., Labots, M., Hoeben, A., Kerver, E. D., Bins, A. D., Erdkamp, F. G. L., van Rooijen, J. M., & 6 othersHoutsma, D., Hendriks, M. P., de Groot, J-W. B., Verheul, H. M. W., Gelderblom, H. & Voest, E. E., 1 Dec 2023, In: BMC Cancer. 23, 1, 205.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  4 Citations (Scopus)

• Limited clinical activity of palbociclib and ribociclib monotherapy in advanced cancers with cyclin D-CDK4/6 pathway alterations in the Dutch DRUP and Australian MoST trials

  Zeverijn, L. J., Looze, E. J., Thavaneswaran, S., van Berge Henegouwen, J. M., Simes, R. J., Hoes, L. R., Sjoquist, K. M., van der Wijngaart, H., Sebastian, L., Geurts, B. S., Lee, C. K., de Wit, G. F., Espinoza, D., Roepman, P., Lin, F. P., Jansen, A. M. L., de Leng, W. W. J., van der Noort, V., Leek, L. V. M., de Vos, F. Y. F. L., & 5 othersvan Herpen, C. M. L., Gelderblom, H., Verheul, H. M. W., Thomas, D. M. & Voest, E. E., 1 Oct 2023, In: International Journal of Cancer. 153, 7, p. 1413-1422 10 p.

  Research output: Contribution to journal › Article › Academic › peer-review
  2 Citations (Scopus)
• 2022

  Efficacy and toxicity of vemurafenib and cobimetinib in relation to plasma concentrations, after administration via feeding tube in patients with BRAF-mutated thyroid cancer: a case series and review of literature

  van Berge Henegouwen, J. M., van der Wijngaart, H., Zeverijn, L. J., Hoes, L. R., Meertens, M., Huitema, A. D. R., Devriese, L. A., Labots, M., Verheul, H. M. W., Voest, E. E. & Gelderblom, H., 1 Jul 2022, In: Cancer Chemotherapy and Pharmacology. 90, 1, p. 97-104 8 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access

• Patients with Rare Cancers in the Drug Rediscovery Protocol (DRUP) Benefit from Genomics-Guided Treatment

  Hoes, L. R., van Berge Henegouwen, J. M., van der Wijngaart, H., Zeverijn, L. J., van der Velden, D. L., van de Haar, J., Roepman, P., de Leng, W. J., Jansen, A. M. L., van Werkhoven, E., van der Noort, V., Huitema, A. D. R., Gort, E. H., de Groot, J. W. B., Kerver, E. D., de Groot, D. J., Erdkamp, F., Beerepoot, L. V., Hendriks, M. P., Smit, E. F., & 10 othersvan der Graaf, W. T. A., van Herpen, C. M. L., Labots, M., Hoeben, A., Morreau, H., Lolkema, M. P., Cuppen, E., Gelderblom, H., Verheul, H. M. W. & Voest, E. E., 1 Apr 2022, In: Clinical Cancer Research. 28, 7, p. 1402-1411 10 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  24 Citations (Scopus)

• Trastuzumab and pertuzumab combination therapy for advanced pre-treated HER2 exon 20-mutated non-small cell lung cancer

  van Berge Henegouwen, J. M., Jebbink, M., Hoes, L. R., van der Wijngaart, H., Zeverijn, L. J., van der Velden, D. L., Roepman, P., de Leng, W. W. J., Jansen, A. M. L., van Werkhoven, E., van der Noort, V., van der Wekken, A. J., de Langen, A. J., Voest, E. E., Verheul, H. M. W., Smit, E. F. & Gelderblom, H., 1 Aug 2022, In: European Journal of Cancer. 171, p. 114-123 10 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  6 Citations (Scopus)
• 2021

  Patients with Biallelic BRCA1/2 Inactivation respond to Olaparib treatment across Histologic tumor types

  Van Der Wijngaart, H., Hoes, L. R., Van Berge Henegouwen, J. M., Van Der Velden, D. L., Zeverijn, L. J., Roepman, P., Van Werkhoven, E., De Leng, W. W. J., Jansen, A. M. L., Mehra, N., Robbrecht, D. G. J., Labots, M., De Groot, D. J. A., Hoeben, A., Hamberg, P., Gelderblom, H., Voest, E. E. & Verheul, H. M. W., 15 Nov 2021, In: Clinical Cancer Research. 27, 22, p. 6106-6114 9 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  9 Citations (Scopus)
• 2019

  Optimal treatment of opioid induced constipation in daily clinical practice - An observational study

  Neefjes, E. C. W., van der Wijngaart, H., van der Vorst, M. J. D. L., ten Oever, D., van der Vliet, H. J., Beeker, A., Rhodius, C. A., van den Berg, H. P., Berkhof, J. & Verheul, H. M. W., 29 Mar 2019, In: BMC palliative care. 18, 1, p. 31 31.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  11 Citations (Scopus)

• Personalised reimbursement: A risk-sharing model for biomarker-driven treatment of rare subgroups of cancer patients

  van Waalwijk van Doorn-Khosrovani, S. B., Pisters-van Roy, A., van Saase, L., van der Graaff, M., Gijzen, J., Sleijfer, S., Hoes, L. R., van Berge Henegouwen, J. M., van der Wijngaart, H., van der Velden, D. L., van Werkhoven, E., Retel, V. P., van Harten, W. H., Huitema, A. D. R., Timmers, L., Gelderblom, H., Verheul, H. M. W. & Voest, E. E., 1 Jan 2019, In: Annals of Oncology. 30, 5, p. 663-665

  Research output: Contribution to journal › Review article › Academic › peer-review

  Open Access
  22 Citations (Scopus)

• The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs

  van der Velden, D. L., Hoes, L. R., van der Wijngaart, H., van Berge Henegouwen, J. M., van Werkhoven, E., Roepman, P., Schilsky, R. L., de Leng, W. W. J., Huitema, A. D. R., Nuijen, B., Nederlof, P. M., van Herpen, C. M. L., de Groot, D. J. A., Devriese, L. A., Hoeben, A., de Jonge, M. J. A., Chalabi, M., Smit, E. F., de Langen, A. J., Mehra, N., & 7 othersLabots, M., Kapiteijn, E., Sleijfer, S., Cuppen, E., Verheul, H. M. W., Gelderblom, H. & Voest, E. E., 3 Oct 2019, In: NATURE. 574, 7776, p. 127-131 5 p.

  Research output: Contribution to journal › Article › Academic › peer-review
  143 Citations (Scopus)
• 2017

  Expanding the use of approved drugs: The CPCT's Drug Rediscovery Protocol (DRUP)

  Voest, E., van der Velden, D., Hoes, L., Bloemendal, H., Grunberg, K., Huitema, A. D. R., Lugtenburg, E., De Vos, F., van Herpen, C., de Groot, D. J. A., Hamberg, P., Smit, E., Cuppen, E., Steeghs, N., Sleijfer, S., Verheul, H., Gelderblom, H. & van der Wijngaart, H., Nov 2017, In: Annals of Oncology. 28, p. x1

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  209 Citations (Scopus)